More rigorous screening called for to mitigate poor outcomes of this common condition.
Read More »Importance of GI Events for GLP-1 Receptor Agonists
Study finds fewer T2 patients on exenatide once-weekly reported gastrointestinal adverse events, compared with those on exenatide twice-daily or liraglutide once-daily.
Read More »Children, Adolescents With Diabetes Might Be Missing Out on Retinopathy Screenings
Race, socioeconomic status thought reasons behind lack of adherence to the recommendations.
Read More »A Major Shift in Diabetes Treatment Targets and Goals
Out with the old, in with the old and new?
Read More »Diet and Diabetes Risk
Are beans really the magical fruit?
Read More »SLGT-2 Inhibitors Gaining Traction as a Class in Preventing Cardiovascular Consequences
Are we experiencing the next “magic bullet” in type 2 diabetes?
Read More »DKA Not Associated With SGLT-2 inhibitors
Study reported SGLT2 Inhibitors monotherapy might not lead to DKA events as opposed to insulin therapy.
Read More »Statin-Induced Diabetes In Women
Risk of type 2 diabetes heightened in elderly women with increase in statin dose.
Read More »“Aspirin Resistance” in Type 2 Diabetes
The reason may be simpler than first thought.
Read More »Delayed Treatment Intensification Can Delay Improved Glycemic Control
Better outcomes with HbA1c reduction associated with intensification of OADs in type 2 diabetes.
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.